Oncogenesis

Oncogenesis is the biological process by which normal cells gradually change into cancer cells through accumulated DNA damage and loss of the body's normal growth controls. It usually unfolds in stages, initiation (the first genetic injury), promotion (the damaged cells multiply), and progression (cells become fully malignant and can spread). This process typically takes years to decades, which is why cancers caused by asbestos often appear long after exposure ended.

Origin

From the Greek onkos (mass or tumor) and genesis (origin or creation). The term entered medical use in the late 19th and early 20th centuries as scientists began to understand cancer as a cellular and genetic disease rather than simply a tumor.

Significance in Asbestos Context

For patients diagnosed with mesothelioma, lung cancer, laryngeal cancer, or ovarian cancer, oncogenesis explains how asbestos fibers inhaled or swallowed decades ago could be responsible for a cancer diagnosed today. Asbestos fibers, especially amphibole types like crocidolite and amosite, lodge in tissue, where they cause chronic inflammation, release of damaging reactive oxygen species, and direct injury to chromosomes. Over many years this damage disables tumor-suppressor genes (such as BAP1, CDKN2A/p16, and NF2 in mesothelioma) and drives the cells toward malignancy. This matters legally because defendants often argue the cancer came from something else, smoking, genetics, or unknown causes. Understanding that cancer typically requires multiple 'hits' allows medical experts to explain that asbestos can be a substantial contributing cause even when other risk factors are also present. The long latency between exposure and diagnosis (often 15–50 years) is also why cases are sometimes filed many decades after a person last worked around asbestos.

Example Sentence

The oncologist explained that her husband's mesothelioma was the end result of an oncogenesis process that likely began with shipyard asbestos exposure in the 1970s.

Related Terms

Carcinogenesis, Latency Period, BAP1 Mutation, Tumor Suppressor Gene, Chronic Inflammation, Multi-Hit Hypothesis

Notes

• Ask your oncologist whether molecular or immunohistochemistry testing (such as BAP1, CDKN2A/p16 by FISH, or NF2) has been done on your tumor tissue. These results can support the link between your cancer and asbestos exposure.
• Preserve pathology slides and tissue blocks; once a hospital discards them, this evidence cannot be recreated. Your medical or legal team can request that the pathology lab retain them.
• Write down a detailed exposure history (jobs, products, locations, dates, secondhand exposure from a family member's work clothes) while memory is fresh. This is what experts use to connect your specific exposures to the oncogenic process.
• If you were exposed decades ago but have no diagnosis, talk to your doctor about appropriate surveillance, such as low-dose CT screening for lung cancer in eligible former smokers, and learn the early symptoms of mesothelioma (persistent chest or abdominal pain, shortness of breath, unexplained weight loss).
• For trust claims and lawsuits, ask that your treating physicians clearly document in the medical record that your cancer is consistent with an asbestos-related cause. This documentation directly affects claim eligibility.